Alpine Immune Sciences, Inc.
ALPN
Revenue
7.03M
▼-23.82M▼-77.21%
3 Months ChangeAssets
373.65M
▼-6.21M▼-1.63%
3 Months ChangeLiabilities
40.94M
▼-10.97M▼-21.13%
3 Months ChangeFree Cash Flow
-27.71M
▼-1.46M▼-5.58%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-05-20
Form 8-K
ID: 0001193125-24-142285
2024-05-09
Form 10-Q
ID: 0001626199-24-000064
2024-05-09
Form 8-K
ID: 0001626199-24-000063
2024-04-10
Form 8-K
ID: 0001193125-24-091936
2024-04-05
Form 8-K
ID: 0001626199-24-000056
2024-03-18
Form 8-K
ID: 0001626199-24-000040
2024-02-07
Form 8-K
ID: 0001626199-24-000030
2024-01-05
Form 8-K
ID: 0001626199-24-000020
2023-12-21
Form 8-K
ID: 0001626199-23-000142
2023-11-14
Form 10-Q
ID: 0001626199-23-000126